Featured News

SDRC News
New Study from the NIH Integrated Islet Distribution Program and DRCs Reveals How Human Pancreatic Islet Cell Composition Shapes Diabetes Risk
New Study from the NIH Integrated Islet Distribution Program and DRCs Reveals How Human Pancreatic Islet Cell Composition Shapes Diabetes Risk

SDRC member Anna Gloyn and others lead efforts mapping diabetes risk to pancreatic islet cell heterogeneity and genes that could drive variation in blood sugar regulation.

Why Ozempic May Not Work for Everyone: SDRC Investigator Anna Gloyn and Colleagues Uncover a Genetic Resistance to GLP-1 Drugs
Why Ozempic May Not Work for Everyone: SDRC Investigator Anna Gloyn and Colleagues Uncover a Genetic Resistance to GLP-1 Drugs

A decade-long study finds that roughly 1 in 10 people carry genetic variants that may blunt the blood sugar-lowering effects of widely used diabetes medications — raising new questions about precision medicine in diabetes care. Read more...

A Python-Derived Molecule Called pTOS Could Point to New Weight-Loss Pathways 
A Python-Derived Molecule Called pTOS Could Point to New Weight-Loss Pathways 

SDRC Investigator Dr. Jonathan Long's latest research reveals how pTOS — a metabolite that surges dramatically in snake blood after a meal — may offer a novel approach to appetite regulation with implications for diabetes care.

More News

Shreya Louis Shreya Louis

Roel Nusse wins $3 million Breakthrough Prize Award

The developmental biologist was honored for helping to decode how Wnt signaling proteins affect embryonic development, cancer and the activity of tissue-specific adult stem cells that repair damage after injury or disease.

Read More